Organism name | Froelichia floridana |
---|---|
Genus | Froelichia |
Family | Amaranthaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Froelichia floridana |
---|---|
Linked NCBI taxonomy ID | 46114 |
Linked level | species |
Family in NCBI taxonomy | Amaranthaceae |
---|---|
ID | 3563 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002518
![]() |
Daidzin
/ Daidzoside / Daidzein 7-O-glucoside |
CHEMBL486422
|
C013908
|
11 / 18 / 41 | 3 / 2 | No. 2 | No. 15 |
![]() |
C00001036
![]() |
Diosmetin
/ 4'-Methylluteolin / 5,7,3'-Trihydroxy-4'-methoxyflavone |
CHEMBL90568
|
C039602
|
11 / 12 / 8 | 5 / 0 | No. 3 | No. 15 |
![]() |
C00033543
![]() |
20-Hydroxyecdysone
|
CHEMBL224128
CHEMBL490151 CHEMBL477132 CHEMBL1707235 CHEMBL2087148 CHEMBL2087156 CHEMBL2087157 CHEMBL2354392 |
6 / 2 / 1 | No. 58 | No. 11 |
![]() |
||
C00048305
![]() |
Achyranthesterone A
/ (+)-Achyranthesterone A |
No. 58 | No. 11 |
![]() |
||||
C00040811
![]() |
2-Dehydro-3-epi-20-hydroxyecdysone
/ (+)-2-Dehydro-3-epi-20-hydroxyecdysone |
No. 58 | No. 11 |
![]() |
||||
C00048279
![]() |
3,4-Dihydroxyphenyl caffeate
|
No. 2442 |
![]() |
|||||
C00048336
![]() |
Blechnoside B
|
No. 4197 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002518 C00033543 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00001036 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002518 | 4 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001036 | 0 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002518 | 1 / 1 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00001036 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00033543 | 1 / 0 |
O75496 | Geminin | Unclassified protein | C00033543 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002518 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002518 | 4 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002518 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001036 | 5 / 3 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00001036 | 4 / 4 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002518 | 7 / 37 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001036 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00001036 | 2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001036 | 1 / 1 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002518 | 1 / 1 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001036 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00033543 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001036 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001036 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002518 | 0 / 0 |
O00167 | Eyes absent homolog 2 | Enzyme | C00033543 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00002518 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002518 | 1 / 1 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00033543 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00002518
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002518
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002518
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001036
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001036
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001036
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001036
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00001036
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#133239 | Esophageal cancer |
P04637
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P04637
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#604229 | Peters anomaly |
Q16678
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
KEGG | name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|